ZURICH, Sept 28 (Reuters) - The following are some of the
main factors expected to affect Swiss stocks on Thursday:
ABB ABBN.S
ABB will not wait "multiple years" to return capital to
investors and this could involve relaunching a share buyback
that was put on hold after the Swiss group bought a unit from
General Electric GE.N , the CEO said on Wednesday. urn:newsml:reuters.com:*:nL8N1M84Z6
UBS UBSG.S
The world's largest wealth manager, is convinced its new
online private bank needs to get bigger. Now it needs to work
out how. urn:newsml:reuters.com:*:nL8N1M83SZ
A former senior precious metals trader at UBS Group AG has
been indicted on a criminal conspiracy charge over his alleged
role in rigging prices by placing "spoof" trades. urn:newsml:reuters.com:*:nL2N1M82LC
NOVARTIS NOVN.S
Novartis's research head expects an alliance with a
University of California chemistry lab to produce drug
candidates within three years as the Swiss company accelerates
its hunt for new medicines. [nNASO0001C
COMPANY STATEMENTS CPR-CH
* Aryzta AG ARYN.S said that Chairman Gary McGann and CEO
Kevin Toland acquired 4,000 and 3,642 ordinary shares of Aryzta
AG respectively following the announcement of full-year 2017
results. ARYN.S
* Panalpina PWTN.S is acquiring Interfresh Airfreight
Handling, a Dutch handling agent specialized in perishables, as
well its affiliates Fresh Cargo Connection and Dutch Cargo
Connection, without disclosing the financial terms of the deal.
* VAT Group VACN.S said Partners Group sold 3 million of
its VAT shares, or roughly 10 percent of total share capital, to
Rudolf Maag. Partners Group will hold a remaining 13.07 percent
of VAT's share post-sale.
* Roche's ROG.S Ocrevus was approved in Switzerland for
primary progressive and relapsing forms of multiple sclerosis.
* SHL Telemedicine SHLTN.S swung back to profitability in
the first six months of 2017, earning net income of $2 million
versus a loss of $3.8 million during H1 2016.
* LumX Group's LUMX.S loss widened to $4.1 million in the
first half of 2017, versus $3.5 million in the prior-year
period.
* Dufry DUFN.S said it won a contract for a downtown
travel retail operation in Kuala Lumpur.
* Basilea BSLN.S has agreed a license with Shenzhen China
Resources Gosun Pharmaceutical Co for Basilea's Zevtera in
China, Hong Kong and Macao. The Swiss group will receive an
execution payment of 3 million francs and is eligible to receive
up to approximately 145 million francs additional payments.
ECONOMY M-CH
(Reporting by Zurich newsroom)
((+41 58 306 7336)(zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit:
https://emea1.views.cp.extranet.thomsonreuters.biz/Explorer/NEWSxTOPNEWS.aspx?group=SP_GROUP_001&page=SP_PAGE_001&pageName=FrontPage
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German................ .SDE
All SMI constituent stocks............................ 0#.SSMI
News on major Swiss stock price moves.................. CH-HOT
FTSE Eurotop 300 index................................ .FTEU3
DJ STOXX index........................................ .STOXX
Top 10 STOXX sectors............................. .PGL.STOXXS
Top 10 EUROSTOXX sectors........................ .PGL.STOXXES
Top 10 Eurotop 300 sectors....................... .PGL.FTEU3S
Top 25 European pct gainers... .PG.PEUR , losers... .PL.PEUR
Swiss mid-cap index .SSMI SMI futures 0#SMI:
Swiss all-share index .SSHI Market statistics CH/STATS1
Swiss market digest .AD.S Sector overview CH/SECTOR1
All Swiss news CH Swiss research news CH-RCH
All equity news E
INTERNET ADDRESSES:
Swiss Exchange www.swx.ch/
Eurex www.eurexchange.com
STOXX Ltd www.stoxx.com
SPEED GUIDES: VX/EQUITY EQUITY EQUITY/NEWS1 EUR/EQUITY
SWITZERLAND REUTERS ))
Keywords: MARKETS SWISS STOCKS/